Myocardial protection during elective coronary artery bypasses grafting by pretreatment with omega-3 polyunsaturated fatty acids;Zaštita srca tokom operacije revaskularizacije srcanog mišica primenom omega-3 nezasicenih masnih kiselina

Vojnosanitetski Pregled

Volumn 70, Issue 5, 2013, Pages 484-492

  Veljovic, Milic ^a,c   Popadic, Ana ^a   Vukic, Zoran ^a   Ilic, Radoje ^b,c   Trifunovic, Zoran ^b   Antunovic, Mirjana ^b,c   Mandaric, Vladimir ^b   Tišma, Svetislav ^b   Markovic, Zoran ^b  

^a Institute of Anesthesiology and Intensive Care   (Serbia)

^b UNIVERSITY OF DEFENCE   (Serbia)

^c Serbia   (Serbia)

Author keywords

Coronary artery bypass; Elective; Fatty acids; Myocardial reperfusion; Omega 3; Surgical procedures

Indexed keywords

CREATINE KINASE MB; OMEGA 3 FATTY ACID; OMEGAVEN; TROPONIN I;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RESPONSE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY SINUS; CREATINE KINASE BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; ELECTIVE SURGERY; FEMALE; HEART FAILURE; HEART INFARCTION; HEART PROTECTION; HUMAN; INFARCTION; MAJOR CLINICAL STUDY; MALE; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RADIAL ARTERY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE;

CORONARY ARTERY BYPASS; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LACTIC ACID; MALE; MIDDLE AGED; MYOCARDIAL REPERFUSION INJURY; OXYGEN; PREOPERATIVE CARE; SURGICAL PROCEDURES, ELECTIVE;

EID: 84875775926     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP1305484V     Document Type: Article

References (48)

1. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 2008; 88(2): 581-609.
2. Salis S, Mazzanti VV, Merli G, Salvi L, Tedesco CC, Veglia F, et al. Cardiopulmonary Bypass Duration Is an Independent Predictor of Morbidity and Mortality After Cardiac Surgery. J Cardiothorac Vasc Anesth 2008; 22(6): 814-822.
3. Ngaage DL, Cowen ME, Cale AR. Cardiopulmonary bypass and left ventricular systolic dysfunction impacts operative mortality differently in elderly and young patients. Eur J Cardiothorac Surg 2009; 35(2): 235-240.
4. Mentzer RM. Myocardial Protection in Heart Surgery. J Cardio-vasc Pharmac Ther 2011; 16(3-4): 290-7.
5. Teshima Y, Akao M, Jones SP, Marbán ECariporide (HOE642), a selective Na+-H+ exchange inhibitor, inhibits the mitochondrial death pathway. Circulation 2003; 108(18): 2275-81.
6. Lell WA, Nielsen VG, McGiffin DC, Schmidt FE Jr, Kirklin JK, Stanley AW. Glucose-insulin-potassium infusion for myocardial protection during off-pump coronary artery surgery. Ann Thorac Surg 2002; 73(4): 1246-1252.
7. Jin Z, Duan W, Chen M, Yu S, Zhang H, Feng G, et al. The myocardial protective effects of adenosine pretreatment in children undergoing cardiac surgery: a randomized controlled clinical trial. Eur J Cardiothorac Surg 2011; 39(5): e90-e96.
8. Wijeysundera DN, Beattie WS, Rao V, Karski J. Calcium antagonists reduce cardiovascular complications after cardiac surgery: a meta-analysis. J Am Coll Cardiol 2003; 41(9): 1496-1505.
9. Carrier M, Pellerin M, Perrault LP, Bouchard D, Page P, Searle N, et al. Cardioplegic Arrest With L-Arginine Improves Myocardial Protection: Results of a Prospective Randomized Clinical Trial. Ann Thorac Surg 2002; 73(3): 837-842.
10. El-Hamamsy I, Stevens LM, Carrier M, Pellerin M, Bouchard D, Demers P, et al. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: A randomized, doubleblind, placebo-controlled clinical trial. J Thorac Cardio-vasc Surg 2007; 133(1): 7-12.
11. Rosenfeldt F, Marasco S, Lyon W, Wowok M, Sheeran F, Bailey M, et al. Coenzime Q 10 therapy before cardiac surgery improves myocardial function and in vitro contracrility of myocardial tissue. J Thorac Cardiovasc Surg 2005; 129(1): 25-32.
12. Deja MA, Malinowski M, Golba KS, Kajor M, Lebda-Wyborny T, Hudziak D, et al. Diazoxide protects myocardial mitochondria, metabolism, and function during cardiac surgery: A double-blind randomized feasibility study of diazoxide-supplemented cardioplegia and Na/H exchange inhibitors. J Thorac Cardiovasc Surg, 2009; 137(4): 997-1004, 1004e-2.
13. Dieleman JM, van Paassen J, van Dijk D, Arbous MS, Kalkman CJ, Vandenbroucke JP, et al. Prophylactic corticosteroids for cardiopulmonary bypass in adults. Cochrane Database Syst Rev 2011; (5): CD005566.
14. Smith PK, Carrier M, Chen JC, Haverich A, Levy JH, Menasché P, et al. Effect of Pexelizumab in Coronary Artery Bypass Graft Surgery With Extended Aortic Cross-Clamp Time. Ann Thorac Surg 2006; 82(3): 781-789.
15. Laurent G, Moe G, Hu X, Holub B, Leong-Poi H, Trogadis J, et al. Long chain n-3 polyunsaturated fatty acids reduce atrial vulnerability in a novel canine pacing model. Cardiovasc Res 2008; 77(1): 89-97.
16. Li GR, Sun HY, Zhang XH, Cheng LC, Chiu SW, Tse HF, et al. Omega-3 polyunsaturated fatty acids inhibit transient outward and ultra-rapid delayed rectifier K1currents and Na1current in human atrial myocytes. Cardiovasc Res 2009; 81(2): 286-293.
17. McGuinness J, Byrne J, Condron C, McCarthy J, Bouchier-Hayes D, Redmond JM. Pretreatment with omega-3 fatty acid infusion to prevent leukocyte-endothelial injury responses seen in cardiac surgery. J Thorac Cardiovasc Surg 2008; 136(1): 135-141.
18. Wang R, Kern JT, Goodfriend TL, Ball DL, Luesch H. Activation of the antioxidant response element by specific oxidized metabolites of linoleicacid. Prostaglandins Leukot Essent Fatty Acids 2009; 81(1): 53-59.
19. Le Guennec JY, Jude S, Besson P, Martel E, Champeroux P. Cardio-protection by omega-3 fatty acids: involvement of PKCs? Prostaglandins Leukot Essent Fatty Acids 2010; 82(4-6): 173-177.
20. McGuinness J, Neilan TG, Sharkasi A, Bouchier-Hayes D, Redmond JM. Myocardial protection using an omega-3 fatty acid infusion: quantification and mechanism of action. J Thorac Cardiovasc Surg 2006; 132(1): 72-79.
21. Richard D, Kefi K, Barbe U, Bausero P, Visioli F. Polyunsaturated fatty acids as antioxidants. Pharmacol Res 2008; 57(6): 451-455.
22. Massaro M, Habib A, Lubrano L, Turco SD, Lazzerini G, Bourcier T, et al. The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition. Proc Natl Acad Sci USA 2006; 103(41): 15184-15189.
23. Nodari S, Triggiani M, Campia U, Manerba A, Milesi G, Cesana BM, et al. Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy. J Am Coll Cardiol 2011; 57(7): 870-879.
24. Mayyas F, Sakurai S, Ram R, Rennison JH, Hwang ES, Castel L, et al. Dietary w3 fatty acids modulate the substrate for postoperative atrial fibrillation in a canine cardiac surgery model. Cardiovasc Res 2011; 89(4): 852-861.
25. Bianconi L, Calò L, Mennuni M, Santini L, Morosetti P, Azzolini P, et al. N-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study. Europace 2011; 13(2): 174-181.
26. Wollert HG, Müller W, Fischer D, Wollert U, Panzner R, Schubert F, et al. Perioperative assessment of cardiac energy metabolism by means of arterio-coronary venous difference in lactate concentration (acDL). A parameter for optimizing ventricular function of the postcardioplegic myocardium. Eur J Cardio-thorac Surg 1990; 4(5): 278-283.
27. Siouffi SY, Kwasnik EM, Khouri SF. Methods for the metabolic quantification of regional myocardial ischemia. J Surg Res 1987; 43(4): 360-378.
28. Vijay P, Szekely L, Aufiero TX, Shap TG. Coronary sinus adre-nomedullin rises in response to myocardial injury. Clin Sci (Lond) 1999; 96(4): 415-420.
29. Koh TW, Hooper J, Kemp M, Ferdinand FD, Gibson DG, Pepper JR. Intraoperative release of troponin T in coronary venous and arterial blood and its relation torecovery of left ventricular function and oxidative metabolism following coronary artery surgery. Heart 1998; 80(4): 341-348.
30. Crittenden MD. Intraoperative metabolic monitoring of the heart: I. Clinical assessment of coronary sinus metabolites. Ann Thorac Surg. 2001; 72(6): S2220-S2226; discussion S2267-70.
31. Rao V, Ivanov J, Weisel RD, Cohen G, Borger MA, Mickle DA. Lactate release during reperfusion predicts low cardiac output syndrome after coronary bypass surgery. Ann Thorac Surg 2001; 71(6): 1925-1930.
32. Shinde SB, Golam KK, Kumar P, Patil ND. Blood lactate levels during cardiopulmonary bypass for valvular heart surgery. Ann Card Anesth 2005; 8(1): 38-44.
33. Kapoor PM, Mandal B, Chowdhury UK, Singh SP, Kiran U. Changes in myocardial lactate, pyruvate and lactate-piruvate ratio during cardiopulmonary bypass for elective adult cardiac surgery: Early indicator of morbidity. J Anesth Clin Pharmac 2011; 27(2): 225-232.
34. Onorati F, Cristodoro L, Caroleo S, Esposito A, Amantea B, Santan-gelo E, et al. Troponin I and lactate from coronary sinus predict cardiac complications after myocardial revascularization. Ann Thorac Surg 2007; 83(3): 1016-1123.
35. Rousou LJ, Crittenden MD, Taylor KB, Healey NA, Gibson S, Thatte HS, et al. Troponin I after cardiac surgery and its implications on myocardial protection, outcomes, and cost. Am J Surg 2008; 196(5): 703-709.
36. Mohiti J, Behjati M, Soltani MH, Babaei A. The significance of troponin T and CK-MB release in coronary bypass surgery. Ind J Clin Bioch 2004; 19(1): 113-117.
37. Mohammed AA, Agnihotri AK, van Kimmenade RRJ, Martinez-Rumayor A, Green SM, Quiroz R, et al. Prospective, comprehensive assessment of cardiac troponin T testing after coronary artery bypass graft surgery. Circulation 2009; 120(10): 843-850.
38. Starkopf J, Andreasen TV, Bugge E, Ytrehus K. Lipid peroxidation, arachidonic acid and products of the lipoxygenase pathway in ischaemic preconditioning of rat heart. Cardiovasc Res 1998; 37(1): 66-75.
39. Pepe S, McLennan PL. Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postishemic recovery of contractile function. Circulation 2002; 105(19): 2303-2308.
40. Richard D, Kefi K, Barbe U, Bausero P, Visioli F. Polyunsaturated fatty acids as antioxidants. Pharmacol Res 2008; 57(5): 451-455.
41. Liu R, Xing J, Miao N, Li W, Liu W, Lai YQ et al. The myocardial protective effect of adenosine as an adjunct to intermittent blood cardioplegia during open heart surgery. Eur J Cardiothorac Surg 2009; 36(6): 1018-1023.
42. Baker WL, Anglade MW, Baker EL, White CM, Kluger J, Coleman CI. Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis. Eur J Cardiothorac Surg 2009; 35(3): 521-527.
43. Ceyhan D, Tanrverdi B, Bilir A. Comparison of the effects of sevoflurane and isoflurane on myocardial protection in coronary bypass surgery. Anadolu Kardiyol Derg 2011; 11(3): 257-262.
44. Howell JN, Ashrafian H, D Phil, Drury NE, Ranasinghe AM, Contractor H, et al. Glucose-Insulin-Potassium Reduces the Incidence of Low Cardiac Output Episodes After Aortic Valve Replacement for Aortic Stenosis in Patients With Left Ventricular Hypertrophy: Results From the Hypertrophy, Insulin, Glucose, and Electrolytes (HINGE) Trial. Circulation 2011; 123(2): 170-177.
45. Gradinac S, Coleman GM, Taegtmeyer H, Sweeny MS, Frazier OH. Improved cardiac function with GIK after aorto-coronary bypass grafting. Ann Thorac Surg 1989; 48: 284-289.
46. Yang Z, Laubach VE, French BA, Kron IL. Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase during reperfusion. J Thorac Cardiovasc Surg 2009; 137(3): 723-729.
47. Albacker TB, Carvalho G, Schricker T, Lachapelle K Myocardial Protection During Elective Coronary Artery Bypass Grafting Using High-Dose Insulin Therapy. Ann Thorac Surg 2007; 84(6): 1920-1927.
48. Smith PK, Carrier M, Chen JC, Haverich A, Levy JH, Menasché P, et al. Effect of Pexelizumab in Coronary Artery Bypass Graft Surgery With Extended Aortic Cross-Clamp Time. Ann Thorac Surg, 2006; 82(3): 781-789.